2937.11.00.00/Mecasermin (Recombinant IGF-1)/Japan

Mecasermin (Recombinant IGF-1) from Japan

Mecasermin is recombinant insulin-like growth factor 1 (IGF-1), a structural analogue closely related to the somatotropin/IGF-1 axis used in severe primary IGF-1 deficiency. While IGF-1 mediates somatotropin effects, its classification follows chapter notes for hormone analogues. HTS 2937.11.00.00 includes such polypeptide hormones used primarily in growth regulation.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Include documentation linking IGF-1 to somatotropin pathway for classification justification

• Ensure compliance with pediatric growth hormone therapy import protocols

• Provide purity certificates (>95%) and endotoxin testing results